HepaRG Maturation in Silk Fibroin Scaffolds: Toward Developing a 3D In Vitro Liver Model

被引:13
作者
Abbott, Alycia [1 ]
Coburn, Jeannine M. [1 ]
机构
[1] Worcester Polytech Inst, Dept Biomed Engn, 100 Inst Rd, Worcester, MA 01609 USA
关键词
hepatocyte maturation; tissueengineering; steatosis; silk fibroin; porousscaffold;
D O I
10.1021/acsbiomaterials.0c01584
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
In vitro liver modelsare necessary tools forthe development of new therapeutics. HepaRG cells are a commonly usedcell line to produce hepatic progenitor cells and hepatocytes. Thisstudy demonstrates for the first time the suitability of 3% silk scaffoldsto support HepaRG growth and differentiation. The modulus and poresize of 3% silk scaffolds were shown to be within the desired rangefor liver cell growth. The optimal seeding density for HepaRG cellson silk scaffolds was determined. The growth and maturation of scaffoldedHepaRG cells was evaluated for 28 days, where the first 14 days ofculture were a proliferation period and the last 14 days of culturewere a differentiation period using dimethyl sulfoxide (DMSO) treatment.After the first 14 days of culture, the scaffolded HepaRG cells exhibitedincreased metabolic activity and albumin secretion compared to monolayercultured controls and preserved these attributes through the durationof culture. Additionally, after the first 14 days of culture, thescaffolded HepaRG cells displayed a significantly reduced expressionof genes associated with hepatocyte maturation. This difference inexpression was no longer apparent after 28 days of culture, suggestingthat the cells underwent rapid differentiation within the scaffold.The functionalization of silk scaffolds with extracellular matrix(ECM) components (type I collagen and/or an arginylglycylasparticacid (RGD)-containing peptide) was investigated to determine the impacton HepaRG cell attachment and maturation. The inclusion of ECM componentshad no noticeable impact on cell attachment but did significantlyinfluence CYP3A4 expression and albumin secretion.Finally, the matrix support provided by the 3% silk scaffolds couldprime the HepaRG cells for steatosis liver model applications, asevidenced by lipid droplet accumulation and expression of steatosis-relatedgenes after 24 h of exposure to oleic acid. Overall, our work demonstratesthe utility of silk scaffolds in providing a modifiable platform forliver cell growth.
引用
收藏
页码:3885 / 3899
页数:15
相关论文
共 90 条
  • [81] Ung Yee Tze, 2018, High Throughput, V7, DOI 10.3390/ht7040029
  • [82] A human liver microphysiology platform for investigating physiology, drug safety, and disease models
    Vernetti, Lawrence A.
    Senutovitch, Nina
    Boltz, Robert
    DeBiasio, Richard
    Shun, Tong Ying
    Gough, Albert
    Taylor, D. Lansing
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (01) : 101 - 114
  • [83] Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions
    Vorrink, Sabine U.
    Zhou, Yitian
    Ingelman-Sundberg, Magnus
    Lauschke, Volker M.
    [J]. TOXICOLOGICAL SCIENCES, 2018, 163 (02) : 655 - 665
  • [84] Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments
    Wang, Bo
    Jakus, Adam E.
    Baptista, Pedro M.
    Soker, Shay
    Soto-Gutierrez, Alejandro
    Abecassis, Michael M.
    Shah, Ramille N.
    Wertheim, Jason A.
    [J]. STEM CELLS TRANSLATIONAL MEDICINE, 2016, 5 (09) : 1257 - 1267
  • [85] HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening
    Wang, Zenan
    Luo, Xiaobei
    Anene-Nzelu, Chukwuemeka
    Yu, Yu
    Hong, Xin
    Singh, Nisha Hari
    Xia, Lei
    Liu, Side
    Yu, Hanry
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 2015, 35 (08) : 909 - 917
  • [86] A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro
    Wang, Zhen-Yu
    Li, Wei-Jian
    Li, Qi-Gen
    Jing, Hong-Shu
    Yuan, Tian-Jie
    Fu, Gong-Bo
    Tang, Dan
    Zhang, Hong-Dan
    Yan, He-Xin
    Zhai, Bo
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 116
  • [87] Engineered Liver Platforms for Different Phases of Drug Development
    Ware, Brenton R.
    Khetani, Salman R.
    [J]. TRENDS IN BIOTECHNOLOGY, 2017, 35 (02) : 172 - 183
  • [88] Tissue mechanics and fibrosis
    Wells, Rebecca G.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (07): : 884 - 890
  • [89] Cell sources for in vitro human liver cell culture models
    Zeilinger, Katrin
    Freyer, Nora
    Damm, Georg
    Seehofer, Daniel
    Knoespel, Fanny
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (15) : 1684 - 1698
  • [90] Effect of oleic acid on induction of steatosis and cytotoxicity in BRL 3A cells
    Zhang, Huiyan
    Wang, Jicang
    Yang, Ling
    Yang, Wenling
    Luo, Tongwang
    Yuan, Yan
    Gu, Jianhong
    Zou, Hui
    Bian, Jianchun
    Liu, Zongping
    Liu, Xuezhong
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (12) : 19541 - 19554